000 | 01012 a2200265 4500 | ||
---|---|---|---|
005 | 20250517211615.0 | ||
264 | 0 | _c20191112 | |
008 | 201911s 0 0 eng d | ||
022 | _a1569-8041 | ||
024 | 7 |
_a10.1093/annonc/mdy131 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTannock, I F | |
245 | 0 | 0 |
_aPurchasing silence. _h[electronic resource] |
260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _c06 2018 |
||
300 |
_a1339-1340 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xeconomics |
650 | 0 | 4 |
_aDrug Industry _xstandards |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aPharmaceutical Preparations _xsupply & distribution |
700 | 1 | _aJoshua, A M | |
773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 29 _gno. 6 _gp. 1339-1340 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdy131 _zAvailable from publisher's website |
999 |
_c28280719 _d28280719 |